Blood loss and transfusion requirements in cystic fibrosis patients undergoing heart-lung or lung transplantation.
Peterson
K L
KL
Department of Anesthesia and Cardiothoracic Surgery, Stanford University School of Medicine, CA 94305, USA.
DeCampli
W M
WM
Feeley
T W
TW
Starnes
V A
VA
D000328:Adult; D015119:Aminocaproic Acid / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion; D002648:Child; D003550:Cystic Fibrosis / Q000601:surgery*; D005164:Factor IX / Q000627:therapeutic use; D016041:Heart-Lung Transplantation; D006801:Humans; D016040:Lung Transplantation; D008297:Male; D010949:Plasma; D017713:Platelet Transfusion
D005164:Factor IX; D007611:Aprotinin; D015119:Aminocaproic Acid